Home Press Release WHO Reaffirms Leprosy-Free Goal Ahead of World Leprosy Day
Press ReleaseVirus & Disease

WHO Reaffirms Leprosy-Free Goal Ahead of World Leprosy Day

Share
World leprosy day
Share

World Leprosy Day on 25 January, the World Health Organization (WHO) has emphasized that ensuring access to treatment remains critical to the global goal of eliminating leprosy.

Leprosy is a long-known infectious disease caused by the bacterium Mycobacterium leprae. It mainly affects the skin and peripheral nerves. If not treated in time, it can lead to permanent disabilities and result in stigma and social exclusion. However, leprosy is fully curable with multidrug therapy (MDT).

Global elimination efforts have significantly reduced new cases in many regions. In 2024, out of 188 reporting countries and territories, 55 recorded zero new cases. Despite this progress, 172,717 new cases were still detected and reported worldwide during the same year.

Strong partnerships have played a key role in these advances. Pharmaceutical companies, particularly Novartis, have been major contributors to leprosy elimination efforts. Since 2000, WHO and Novartis have worked together to provide MDT and clofazimine free of charge to leprosy patients globally—making this one of the longest-running medicine donation programmes in global health.

To mark 25 years of collaboration, WHO and Novartis have renewed their Memorandum of Understanding for another five years (2026–2030). The renewed agreement ensures the continued supply of MDT and also includes financial support for the procurement and distribution of single-dose rifampicin for post-exposure prophylaxis.

Dr Jeremy Farrar, WHO Assistant Director-General for Health Promotion, Disease Prevention and Care. Highlighted the importance of this partnership, noting that sustained support from partners like Novartis has been central to progress against leprosy. He emphasized that free access to treatment has transformed millions of lives and demonstrated the impact of global collaboration rooted in science, equity and shared commitment.

The availability of free MDT has enabled effective cure, disability prevention and stigma reduction. Allowing affected individuals to live productive lives. Clofazimine has also been crucial in managing lepra reactions—severe inflammatory episodes that can cause lasting disabilities if untreated.

Dr Lutz Hegemann, President of Global Health at Novartis, reaffirmed the company’s commitment, stating that combating leprosy has long been part of Novartis’ legacy. Over the past 25 years, the partnership with WHO has reached millions of patients and the company remains dedicated to advancing the goal of a leprosy-free world.

Despite substantial achievements, continued political will, community involvement and strong partnerships are essential to sustain progress.

The theme of World Leprosy Day this year is “Leprosy is curable, the real challenge is stigma.”

This year also marks 25 years of service by Mr Yohei Sasakawa as WHO Goodwill Ambassador for Leprosy Elimination. He underscored that stigma often poses a greater challenge than the disease itself, particularly for those left with disabilities. Even after cured, many individuals face discrimination such as forced separation, loss of education or employment, and long-term social exclusion.

As leprosy is among the Neglected Tropical Diseases (NTDs). These efforts also contribute to the broader global mission to eliminate NTDs. WHO encourages participation in collective action through World NTD Day 2026, to observed on 30 January.

Share
Written by
kirti Shah

Kirti is a Health Editor at Healthwire Media, specializing in health journalism and digital health communication. With over four years of experience in the healthcare media landscape, she is dedicated to transforming complex clinical data into accessible, patient-friendly information. Kirti oversees the editorial lifecycle of every article, ensuring they meet rigorous fact-checking standards and align with the latest guidelines from primary sources like the WHO and Ministry of Health. In her role, Kirti works closely with a panel of board-certified physicians and medical reviewers to ensure that every piece of content published is not only easy to understand but also medically accurate and safe for the public. She is passionate about health literacy and helping readers navigate their wellness journeys with confidence.

Don't Miss

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as infections continue to spread across parts of Central and East Africa....

WHO
Health TipsInternational NewsLatest NewsLifestyle & WellnessWHO

WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know

More than 100 years after the discovery of insulin, millions of people living with type 1 diabetes continue to face challenges in accessing...

Breast Cancer
Health NewsOncology

Mammogram vs Ultrasound vs MRI: Which Breast Cancer Screening Test Is Right for You?

Breast cancer is one of the most common cancers affecting women worldwide, and early detection plays an important role in improving treatment outcomes....

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Section title

Related Articles
Virus & Disease

No Approved Vaccine Yet: What Makes The Bundibugyo Ebola Strain So Dangerous?

The ongoing Bundibugyo Ebola outbreak has raised concerns among global health authorities,...

World’s First Dual-Console Complex Robotic Beating-Heart TECAB Surgery Performed in India using Made in India technology
Press Release

World’s First Dual-Console Complex Robotic Beating-Heart TECAB Surgery Performed in India using Made in India technology

The landmark beating-heart TECAB procedure performed at Medanta Hospital using SSI Mantra...

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as...